The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Entegris's revenues will grow 1.5% and EPS will decrease -21.4%.
The average estimate for revenue is $166.3 million. On the bottom line, the average EPS estimate is $0.11.
Last quarter, Entegris recorded revenue of $184.4 million. GAAP reported sales were 6.6% higher than the prior-year quarter's $173.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.16. GAAP EPS of $0.13 for Q3 were 19% lower than the prior-year quarter's $0.16 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 44.4%, 120 basis points better than the prior-year quarter. Operating margin was 16.8%, 130 basis points better than the prior-year quarter. Net margin was 9.8%, 290 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $714.2 million. The average EPS estimate is $0.57.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 134 members out of 148 rating the stock outperform, and 14 members rating it underperform. Among 34 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give Entegris a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Entegris is outperform, with an average price target of $11.00.
Is Entegris the best semiconductor stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Entegris to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Shares of Entegris Inc. Jumped Today
The supplier to the semiconductor industry blew past analyst estimates, giving investors a good reason to pile into the stock.
Why ATMI, Inc. Shares Skyrocketed
Is ATMI's jump meaningful? Or just another movement?
Why Furiex Pharmaceuticals, Lionbridge Technologies, and ATMI Are Today's 3 Best Stocks
The S&P 500 stages a modest rebound, Furiex Pharmaceuticals more than doubles, and Lionbridge Technology and ATMI respectively surge by 29% and 25%.